Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
12:00 AM - DEVICE TALKS
9
11
12
13
14
16
18
19
20
21
22
23
24
26
27
28
29
30
31
1
2
3
4
DEVICE TALKS
DEVICE TALKS BOSTON 2018: BIGGER AND BETTER THAN EVER! Join us Oct. 8-10 for the 7th annual DeviceTalks Boston, back in the city where it [...]
6th Annual HealthIMPACT Midwest
2018-10-10    
All Day
REV1 VENTURES COLUMBUS, OH The Provider-Patient Experience Summit - Disrupting Delivery without Disrupting Care HealthIMPACT Midwest is focused on technologies impacting clinician satisfaction and performance. [...]
15 Oct
2018-10-15 - 2018-10-16    
All Day
Conference Series Ltd invites all the participants from all over the world to attend “3rd International Conference on Environmental Health” during October 15-16, 2018 in Warsaw, Poland which includes prompt keynote [...]
17 Oct
2018-10-17 - 2018-10-19    
7:00 am - 6:00 pm
BALANCING TECHNOLOGY AND THE HUMAN ELEMENT In an era when digital technologies enable individuals to track health statistics such as daily activity and vital signs, [...]
Epigenetics Congress 2018
2018-10-25 - 2018-10-26    
All Day
Conference: 5th World Congress on Epigenetics and Chromosome Date: October 25-26, 2018 Place: Istanbul, Turkey Email: epigeneticscongress@gmail.com About Conference: Epigenetics congress 2018 invites all the [...]
Events on 2018-10-08
DEVICE TALKS
8 Oct 18
425 Summer Street
Events on 2018-10-10
Events on 2018-10-17
17 Oct
Events on 2018-10-25
Epigenetics Congress 2018
25 Oct 18
Istanbul
Articles

Primary Prevention of Alzheimer’s Disease Utilizing EMR

Primary Prevention of Alzheimer’s Disease Utilizing the Electronic Medical Record (EMR) Novel approach could have important implications in identifying and treating patients at-risk of Alzheimer’s disease Evanston, IL, Jan.31, 2017 – A paper published online in the Journal of Prevention of Alzheimer’s Disease reports on a health system-wide primary prevention initiative that harnesses the power of the Electronic Medical Record (EMR). Authors report utilizing the EMR to identify and guide treatment for patients at high risk for Alzheimer’s disease, Parkinson’s disease and Chronic Traumatic Encephalopathy (CTE).

An electronic medical record-based (EMR) clinical documentation support toolkit aided in identifying high-risk individuals while evaluating risk factors and history. The toolkit includes evidence-based interventions to modify risk and features built-in capacity for pragmatic clinical trials and genomic research.

“Our purpose is to primarily prevent Alzheimer’s disease and related disorders through EMR-based screening, risk assessments, interventions and surveillance,” said Demetrius Maraganore, MD, corresponding author, Chairman of the Department of Neurology and Director of the Center for Brain Health at NorthShore University HealthSystem (NorthShore). “We are translating research into primary prevention of Alzheimer’s disease and aim to shift the paradigm in neurology from brain disease to brain health.”

Alzheimer’s disease and aging brain disorders are progressive, often fatal neurodegenerative diseases. Successful aging, modern lifestyles and behaviors have combined to result in an expected epidemic. Risks for these diseases include genetic, medical and lifestyle factors; over 20 modifiable risks have been reported.

The paper describes the Center for Brain Health at NorthShore, the EMR tools, the first year of patients and characterizes the opportunities for risk mitigation. “We have made progress in identifying high-risk individuals within a population and engaging them in care. We demonstrate that this is possible in a large health system and that leveraging the EMR and analytics can automate efforts and create learning opportunities,” said Anne Marie Fosnacht, MPH, first author and Sr. Clinical Research Associate at the Center for Brain Health.

“Additionally, through our Neurology Practice Based Research Network, we aim to share our EMR tools and data which will vastly increase our ability to improve the quality of the care we provide, to make new discoveries relating to brain health, to achieve better outcomes and ultimately reduce the burden of brain disorders in the communities we serve.”